Gilberto Fisone - Publications

Neuroscience Karolinska Institute, Stockholm, Sweden 

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Smedler E, Louhivuori L, Romanov RA, Masini D, Dehnisch Ellström I, Wang C, Caramia M, West Z, Zhang S, Rebellato P, Malmersjö S, Brusini I, Kanatani S, Fisone G, Harkany T, et al. Disrupted gene expression perturbs spontaneous Ca activity causing abnormal brain development and increased anxiety. Proceedings of the National Academy of Sciences of the United States of America. 119. PMID 35135875 DOI: 10.1073/pnas.2108768119  0.761
2021 Masini D, Plewnia C, Bertho M, Scalbert N, Caggiano V, Fisone G. A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson's Disease for the Study of Non-Motor Symptoms. Biomedicines. 9. PMID 34070345 DOI: 10.3390/biomedicines9060598  0.788
2020 Plewnia C, Masini D, Fisone G. P.327 Non-motor complications induced by dopamine replacement therapy in a mouse model of Parkinson's disease European Neuropsychopharmacology. 31: S67. DOI: 10.1016/J.Euroneuro.2019.12.090  0.762
2018 Stagkourakis S, Spigolon G, Williams P, Protzmann J, Fisone G, Broberger C. A neural network for intermale aggression to establish social hierarchy. Nature Neuroscience. 21: 834-842. PMID 29802391 DOI: 10.1038/S41593-018-0153-X  0.58
2018 Masini D, Bonito-Oliva A, Bertho M, Fisone G. Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson's Disease. Frontiers in Neurology. 9: 208. PMID 29686643 DOI: 10.3389/Fneur.2018.00208  0.791
2018 Spigolon G, Fisone G. Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29396608 DOI: 10.1007/S00702-018-1847-7  0.367
2018 Caggiano V, Leiras R, Goñi-Erro H, Masini D, Bellardita C, Bouvier J, Caldeira V, Fisone G, Kiehn O. Midbrain circuits that set locomotor speed and gait selection. Nature. PMID 29342142 DOI: 10.1038/Nature25448  0.762
2017 Spigolon G, Cavaccini A, Trusel M, Tonini R, Fisone G. cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease. Neurobiology of Disease. PMID 29107639 DOI: 10.1016/J.Nbd.2017.10.015  0.381
2017 di Val Cervo PR, Romanov RA, Spigolon G, Masini D, Martín-Montañez E, Toledo EM, La Manno G, Feyder M, Pifl C, Ng YH, Sánchez SP, Linnarsson S, Wernig M, Harkany T, Fisone G, et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nature Biotechnology. PMID 28398344 DOI: 10.1038/Nbt.3835  0.778
2017 Masini D, Lopes-Aguiar C, Bonito-Oliva A, Papadia D, Andersson R, Fisahn A, Fisone G. The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism. Translational Psychiatry. 7. PMID 28398338 DOI: 10.1038/Tp.2017.58  0.776
2016 Bonito-Oliva A, Södersten E, Spigolon G, Hu X, Hellysaz A, Falconi A, Gomes AL, Broberger C, Hansen K, Fisone G. Differential Regulation of the Phosphorylation of Trimethyl-lysine27 Histone H3 at Serine 28 in Distinct Populations of Striatal Projection Neurons. Neuropharmacology. PMID 26947946 DOI: 10.1016/J.Neuropharm.2016.02.037  0.637
2014 Bonito-Oliva A, Masini D, Fisone G. A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions. Frontiers in Behavioral Neuroscience. 8: 290. PMID 25221486 DOI: 10.3389/Fnbeh.2014.00290  0.803
2014 Mango D, Bonito-Oliva A, Ledonne A, Cappellacci L, Petrelli R, Nisticò R, Berretta N, Fisone G, Mercuri NB. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice. Experimental Neurology. 261: 733-43. PMID 25173217 DOI: 10.1016/J.Expneurol.2014.08.022  0.308
2014 Mango D, Bonito-Oliva A, Ledonne A, Nisticò R, Castelli V, Giorgi M, Sancesario G, Fisone G, Berretta N, Mercuri NB. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions. Neuropharmacology. 76: 127-36. PMID 23973317 DOI: 10.1016/J.Neuropharm.2013.08.010  0.307
2013 Bonito-Oliva A, Pallottino S, Bertran-Gonzalez J, Girault JA, Valjent E, Fisone G. Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1. Neuropharmacology. 72: 197-203. PMID 23643747 DOI: 10.1016/J.Neuropharm.2013.04.043  0.326
2013 Dell'anno MT, Pallottino S, Fisone G. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons. Neuropharmacology. 66: 179-86. PMID 22507666 DOI: 10.1016/J.Neuropharm.2012.03.025  0.806
2012 Santini E, Feyder M, Gangarossa G, Bateup HS, Greengard P, Fisone G. Dopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism. The Journal of Biological Chemistry. 287: 27806-12. PMID 22753408 DOI: 10.1074/Jbc.M112.388413  0.351
2011 Feyder M, Bonito-Oliva A, Fisone G. L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission. Frontiers in Behavioral Neuroscience. 5: 71. PMID 22028687 DOI: 10.3389/Fnbeh.2011.00071  0.38
2011 Valjent E, Bertran-Gonzalez J, Bowling H, Lopez S, Santini E, Matamales M, Bonito-Oliva A, Hervé D, Hoeffer C, Klann E, Girault JA, Fisone G. Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2561-70. PMID 21814187 DOI: 10.1038/Npp.2011.144  0.349
2011 Bonito-Oliva A, Feyder M, Fisone G. Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling. Frontiers in Neuroanatomy. 5: 38. PMID 21808606 DOI: 10.3389/Fnana.2011.00038  0.38
2011 Gangarossa G, Di Benedetto M, O'Sullivan GJ, Dunleavy M, Alcacer C, Bonito-Oliva A, Henshall DC, Waddington JL, Valjent E, Fisone G. Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus. Plos One. 6: e19415. PMID 21559295 DOI: 10.1371/Journal.Pone.0019415  0.306
2010 Santini E, Sgambato-Faure V, Li Q, Savasta M, Dovero S, Fisone G, Bezard E. Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. Plos One. 5: e12322. PMID 20808799 DOI: 10.1371/Journal.Pone.0012322  0.316
2010 Bateup HS, Santini E, Shen W, Birnbaum S, Valjent E, Surmeier DJ, Fisone G, Nestler EJ, Greengard P. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proceedings of the National Academy of Sciences of the United States of America. 107: 14845-50. PMID 20682746 DOI: 10.1073/Pnas.1009874107  0.322
2010 Santini E, Valjent E, Fisone G. mTORC1 signaling in Parkinson's disease and L-DOPA-induced dyskinesia: A sensitized matter. Cell Cycle (Georgetown, Tex.). 9: 2713-8. PMID 20581466 DOI: 10.4161/Cc.9.14.12323  0.36
2009 Santini E, Heiman M, Greengard P, Valjent E, Fisone G. Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. Science Signaling. 2: ra36. PMID 19622833 DOI: 10.1126/Scisignal.2000308  0.335
2009 Santini E, Alcacer C, Cacciatore S, Heiman M, Hervé D, Greengard P, Girault JA, Valjent E, Fisone G. L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice. Journal of Neurochemistry. 108: 621-33. PMID 19187092 DOI: 10.1111/J.1471-4159.2008.05831.X  0.363
2009 Bertran-Gonzalez J, Håkansson K, Borgkvist A, Irinopoulou T, Brami-Cherrier K, Usiello A, Greengard P, Hervé D, Girault JA, Valjent E, Fisone G. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1710-20. PMID 19158668 DOI: 10.1038/Npp.2008.228  0.321
2008 Santini E, Valjent E, Fisone G. Parkinson's disease: levodopa-induced dyskinesia and signal transduction. The Febs Journal. 275: 1392-9. PMID 18279379 DOI: 10.1111/J.1742-4658.2008.06296.X  0.347
2008 Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, Herve D, Pasqualetti M, Di Lauro R, Fisone G, Usiello A. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Molecular and Cellular Neurosciences. 37: 335-45. PMID 18035555 DOI: 10.1016/J.Mcn.2007.10.007  0.344
2008 Borgkvist A, Marcellino D, Fuxe K, Greengard P, Fisone G. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol. Neuropharmacology. 54: 31-5. PMID 17686497 DOI: 10.1016/J.Neuropharm.2007.06.025  0.326
2007 Santini E, Valjent E, Usiello A, Carta M, Borgkvist A, Girault JA, Hervé D, Greengard P, Fisone G. Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6995-7005. PMID 17596448 DOI: 10.1523/Jneurosci.0852-07.2007  0.335
2006 Håkansson K, Galdi S, Hendrick J, Snyder G, Greengard P, Fisone G. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. Journal of Neurochemistry. 96: 482-8. PMID 16336634 DOI: 10.1111/J.1471-4159.2005.03558.X  0.356
2005 Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, Svenningsson P, Fredholm BB, Borrelli E, Greengard P, Fisone G. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8432-8. PMID 16162925 DOI: 10.1523/Jneurosci.1289-05.2005  0.738
2005 Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark H, Leriche L, HÃ¥kansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich EV, et al. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism & Related Disorders. 11: S25-9. PMID 15885624 DOI: 10.1016/J.Parkreldis.2004.11.005  0.313
2005 Aubert I, Guigoni C, HÃ¥kansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Annals of Neurology. 57: 17-26. PMID 15514976 DOI: 10.1002/Ana.20296  0.343
2004 Håkansson K, Pozzi L, Usiello A, Haycock J, Borrelli E, Fisone G. Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol European Journal of Neuroscience. 20: 1108-1112. PMID 15305880 DOI: 10.1111/J.1460-9568.2004.03547.X  0.747
2004 Håkansson K, Lindskog M, Pozzi L, Usiello A, Fisone G. DARPP-32 and modulation of cAMP signaling: Involvement in motor control and levodopa-induced dyskinesia Parkinsonism and Related Disorders. 10: 281-286. PMID 15196506 DOI: 10.1016/J.Parkreldis.2004.02.010  0.741
2004 Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. DARPP-32: an integrator of neurotransmission. Annual Review of Pharmacology and Toxicology. 44: 269-96. PMID 14744247 DOI: 10.1146/Annurev.Pharmtox.44.101802.121415  0.303
2003 Pozzi L, HÃ¥kansson K, Usiello A, Borgkvist A, Lindskog M, Greengard P, Fisone G. Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. Journal of Neurochemistry. 86: 451-9. PMID 12871586 DOI: 10.1046/J.1471-4159.2003.01851.X  0.723
2003 Lindgren N, Usiello A, Goiny M, Haycock J, Erbs E, Greengard P, Hokfelt T, Borrelli E, Fisone G. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proceedings of the National Academy of Sciences of the United States of America. 100: 4305-9. PMID 12651945 DOI: 10.1073/Pnas.0730708100  0.303
2002 Hökfelt T, Blacker D, Broberger C, Herrera-Marschitz M, Snyder G, Fisone G, Cortés R, Morino P, You ZB, Ogren SO. Some aspects on the anatomy and function of central cholecystokinin systems. Pharmacology & Toxicology. 91: 382-6. PMID 12688383 DOI: 10.1034/J.1600-0773.2002.910617.X  0.626
2002 Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, Fredholm BB, Nairn AC, Greengard P, Fisone G. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature. 418: 774-8. PMID 12181566 DOI: 10.1038/Nature00817  0.725
2002 Lindgren N, Goiny M, Herrera-Marschitz M, Haycock JW, Hökfelt T, Fisone G. Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. The European Journal of Neuroscience. 15: 769-73. PMID 11886455 DOI: 10.1046/J.1460-9568.2002.01901.X  0.304
2001 Lindgren N, Xu ZQ, Herrera-Marschitz M, Haycock J, Hökfelt T, Fisone G. Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. The European Journal of Neuroscience. 13: 773-80. PMID 11207812 DOI: 10.1046/J.0953-816X.2000.01443.X  0.351
2000 Svenningsson P, Fienberg AA, Allen PB, Moine CL, Lindskog M, Fisone G, Greengard P, Fredholm BB. Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32. Journal of Neurochemistry. 75: 248-57. PMID 10854268 DOI: 10.1046/J.1471-4159.2000.0750248.X  0.305
2000 Lindgren N, Xu ZQ, Lindskog M, Herrera-Marschitz M, Goiny M, Haycock J, Goldstein M, Hökfelt T, Fisone G. Regulation of tyrosine hydroxylase activity and phosphorylation at Ser(19) and Ser(40) via activation of glutamate NMDA receptors in rat striatum. Journal of Neurochemistry. 74: 2470-7. PMID 10820208 DOI: 10.1046/J.1471-4159.2000.0742470.X  0.314
2000 Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proceedings of the National Academy of Sciences of the United States of America. 97: 1856-60. PMID 10677546 DOI: 10.1073/Pnas.97.4.1856  0.306
1999 Nishi A, Snyder GL, Fienberg AA, Fisone G, Aperia A, Nairn AC, Greengard P. Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation. The European Journal of Neuroscience. 11: 2589-92. PMID 10383649 DOI: 10.1046/J.1460-9568.1999.00724.X  0.311
1999 Lindskog M, Svenningsson P, Fredholm B, Greengard P, Fisone G. Mu- and delta-opioid receptor agonists inhibit DARPP-32 phosphorylation in distinct populations of striatal projection neurons. The European Journal of Neuroscience. 11: 2182-6. PMID 10336688 DOI: 10.1046/J.1460-9568.1999.00597.X  0.313
1999 Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience. 88: 1005-8. PMID 10336115 DOI: 10.1016/S0306-4522(98)00411-4  0.318
1998 Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience. 84: 223-8. PMID 9522376 DOI: 10.1016/S0306-4522(97)00510-1  0.363
1993 Snyder GL, Fisone G, Morino P, Gundersen V, Ottersen OP, Hökfelt T, Greengard P. Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum. Proceedings of the National Academy of Sciences of the United States of America. 90: 11277-81. PMID 8248241 DOI: 10.1073/Pnas.90.23.11277  0.307
Show low-probability matches.